MainScienceBiologyBiochemistry and Molecular Biology › Imgenex Corp.

Imgenex Corp.

Edit Page
Report
Scan day: 04 March 2014 UTC
8
Virus safety - good
Description: Develops and commercializes antibodies, gene and protein expression systems, and tissue arrays, and siRNA interference systems for use in studies of functional genomics. Offers custom synthesis, in San Diego, California.
Antibodies, TLR, Toll-like Receptors, NF-kb, Apoptosis, Tissue Lysates, Cancer Biomarkers, Chromatin Immunoprecipitation, Caspase Antibodies PATHWAY PROFILING ANTIBODIES & REAGENTS IMGENEX Corporation is now NOVUS BIOLOGICALS
Size: 233 chars

Contact Information

Email:
Phone&Fax:
Address:
Extended:

WEBSITE Info

Page title:Antibodies, TLR, Toll-like Receptors, NF-kb, Apoptosis, Tissue Lysates, Cancer Biomarkers, Chromatin Immunoprecipitation, Caspase Antibodies
Keywords:antibody polyclonal production, antigen, chemokines, cytokines, dna methylation, elisa kits, gene expression, gene silencing, genomics,interlukin,monoclonal antibodies, protein expression, polyclonal antibody, reagents, rna interference, sars, sars virus, sirna, smad proteins and activators, tissue array, tissue microarrays, toll-like receptors, transcription factors, custom service, custom polyclonal antibody, polyclonal antibody service, custom project
Description:Imgenex Corp. develops novel reagents, including antibodies, gene and protein expression systems, and arrays of various cells and tissues for use in studies of functional genomics. If you study cancer, apoptosis, molecular signaling pathways, cellular aging make sure to request our catalog today!
IP-address:108.166.9.116

WHOIS Info

NS
Name Server: NS10.DNSMADEEASY.COM
Name Server: NS11.DNSMADEEASY.COM
Name Server: NS12.DNSMADEEASY.COM
Name Server: NS13.DNSMADEEASY.COM
Name Server: NS14.DNSMADEEASY.COM
Name Server: NS15.DNSMADEEASY.COM
WHOIS
Status: clientDeleteProhibited
Status: clientRenewProhibited
Status: clientTransferProhibited
Status: clientUpdateProhibited
Date
Creation Date: 05-dec-1997
Expiration Date: 04-dec-2016